Evidence map›Paper›PMID 29746472›Full record

ArticlePLoS computational biology2018

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach.

Arturo Blazquez-Navarro, Thomas Schachtner, Ulrik Stervbo, Anett Sefrin, Maik Stein, Timm H Westhoff, Petra Reinke, Edda Klipp, Nina Babel, Avidan U Neumann and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. T-cell adoptive immunotherapy for BK nephropathy in renal transplantation.Transplant infectious disease : an official journal of the Transplantation Society · 2020
    Article
  7. Article
  8. Validated Models of Immune Response to Virus Infection.Current opinion in systems biology · 2018
    Article
  9. Cellular Immunity Against BK Polyomavirus in Kidney Transplant Recipients: A Comprehensive Review.Transplant infectious disease : an official journal of the Transplantation Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Arturo Blazquez-NavarroBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.ORCID 0000-0002-2972-7962
Thomas SchachtnerBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.
Ulrik StervboBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.ORCID 0000-0002-2831-8868
Anett SefrinDepartment of Nephrology and Internal Intensive Care, Charité-Universitätsmedizin, Berlin, Germany.
Maik SteinBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.
Timm H WesthoffMedical Clinic I, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany.
Petra ReinkeBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.
Edda KlippTheoretical Biophysics Group, Department of Biology, Humboldt-Universität zu Berlin, Berlin, Germany.
Nina BabelBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.
Avidan U NeumannBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany.
Michal Or-GuilSystems Immunology Lab, Department of Biology, Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5576-8883
Berlin-Brandenburger Centrum für Regenerative Therapien · DEHumboldt-Universität zu Berlin · DEUniversitätsklinik Marien Hospital Herne · DECharité - Universitätsmedizin Berlin · DEHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BK virus (BKV) associated nephropathy affects 1-10% of kidney transplant recipients, leading to graft failure in about 50% of cases. Immune responses against different BKV antigens have been shown to have a prognostic value for disease development. Data currently suggest that the structural antigens and regulatory antigens of BKV might each trigger a different mode of action of the immune response. To study the influence of different modes of action of the cellular immune response on BKV clearance dynamics, we have analysed the kinetics of BKV plasma load and anti-BKV T cell response (Elispot) in six patients with BKV associated nephropathy using ODE modelling. The results show that only a small number of hypotheses on the mode of action are compatible with the empirical data. The hypothesis with the highest empirical support is that structural antigens trigger blocking of virus production from infected cells, whereas regulatory antigens trigger an acceleration of death of infected cells. These differential modes of action could be important for our understanding of BKV resolution, as according to the hypothesis, only regulatory antigens would trigger a fast and continuous clearance of the viral load. Other hypotheses showed a lower degree of empirical support, but could potentially explain the clearing mechanisms of individual patients. Our results highlight the heterogeneity of the dynamics, including the delay between immune response against structural versus regulatory antigens, and its relevance for BKV clearance. Our modelling approach is the first that studies the process of BKV clearance by bringing together viral and immune kinetics and can provide a framework for personalised hypotheses generation on the interrelations between cellular immunity and viral dynamics.

Indexed as

Kidney DiseasesPolyomavirus InfectionsAntigens, ViralBK VirusComputational BiologyEnzyme-Linked Immunospot AssayHost-Pathogen InteractionsHumansKidney TransplantationKineticsModels, BiologicalT-LymphocytesViral LoadAntigens, Viral

Identifiers

PMID29746472
PMCPMC5944912
OpenAlexW2800306690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.